The Clinic Edition covers up to 5 providers, so your whole team can deliver consistent, certified care and every eligible provider gets their own CWMP designation
There is no clinical evidence showing weight gain is caused by taking spironolactone
Mozaffarian D, Agarwal M, Aggarwal M, Alexander L, Apovian CM, Bindlish S, Bonnet J, Butsch WS, Christensen S, Gianos E, Gulati M, Gupta A, Horn D, Kane RM, Saluja J, Sannidhi D, Stanford FC, Callahan EA
Andrs Quintana Roo 899, Repobladores, 77660 Cozumel, Q.R
In these cases, its best to talk to your doctor or a mental health professional to seek guidance
The MHRA has approved specific GLP-1 receptor agonists for weight management (Wegovy and Saxenda) in individuals with a body mass index (BMI) of 30 kg/m or above, or 27 kg/m with weight-related comorbidities, while others are approved only for glycaemic control in type 2 diabetes